ATS View
한국어

Daewoong KRX:003090KOSPI

대웅 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h4
Articles, 7 days8
DART filings, 7 days0
Articles tracked53since Sep 11

In Q2 2026, Daewoong reported revenue of ₩571bn, up 8.0% year on year, and operating profit of ₩76.6bn. Daewoong (대웅) appeared in 8 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 29 with 6 articles. The most common catalyst was policy & overseas (3). It was most often mentioned alongside 글로벌테크놀로지, Hugel and Medy-Tox.

Daewoong quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩571bn+8.0%₩76.6bn
margin 13.4%		₩36.3bn
Q1 2026₩493bn+2.3%₩47.8bn
margin 9.7%		₩53.3bn
Q4 2025 derived₩516bn–₩34.8bn
margin 6.7%		₩69.4bn
Q3 2025₩542bn–₩80.5bn
margin 14.9%		₩62.7bn
Q2 2025₩528bn+11.6%₩85.3bn
margin 16.1%		₩61.3bn
Q1 2025₩481bn+8.5%₩61.1bn
margin 12.7%		₩34.5bn
Q4 2024 derived––₩63.0bn−₩32.5bn
Q3 2024––₩102bn₩58.0bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Daewoong top stories 2 weeks, by number of outlets

  1. 1
    국제성모병원·대웅 얼라이언스, 디지털헬스 해외 진출 협력
    2 outlets · 2 articlesFirst report Oct 29 15:42 메디파나뉴스Overseas expansion
  2. 2
    국제성모병원-대웅 얼라이언스, 글로벌 진출 추진
    2 outlets · 2 articlesFirst report Oct 29 19:46 병원신문Overseas expansion글로벌테크놀로지
  3. 3
    대웅 한올바이오 '바토클리맙', 中 중증근무력증 허가…마일스톤·로열티 기대
    1 outlets · 1 articlesFirst report Oct 23 09:54 더구루Licensing deal
  4. 4
    대웅 다나아데이터, '통합 AI 건강관리 서비스' 출시
    1 outlets · 1 articlesFirst report Oct 29 10:15 핀포인트뉴스
  5. 5
    유한 對 대웅, 병상 넘어 일상으로 … 웨어러블 생체신호 모니터링 전면전
    1 outlets · 1 articlesFirst report Oct 20 07:49 헬스코리아뉴스
  6. 6
    대웅, 이온 지분 45.7→20.3%…美증자로 ABP-450 임상 재원 확충
    1 outlets · 1 articlesFirst report Oct 27 07:54 메디코파마

Latest Daewoong news Korean headlines